NCT06153602 - Effectiveness of Nalbuphine as an Adjuvant to Subarachnoid Block on Postoperative Analgesia in TURP Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 7, 2023

Primary Completion Date

November 27, 2024

Study Completion Date

November 28, 2024

Conditions

Transurethral Resection of Prostate

Interventions

DRUG

Nalbuphine Hydrochloride 10 MG/ML

Nalbuphine(10mg/ml) 0.8 mg intrathecal

DRUG

Sodium Chloride 0.9 % in 5 ML Injection

0.9% Sodium Chloride 0.08 ml intrathecal

DRUG

Bupivacaine Hydrochloride, Spinal

0.5% Hyperbaric or Isobaric Spinal Bupivacaine 1-4 ml intrathecal

DRUG

Nalbuphine Hcl 10Mg/Ml Inj

4 mg IV prn for postoperative pain score\>=4 q 6 h

DRUG

Acetaminophen 500Mg Tab

1 tab oral prn for postoperative pain score 1-3 q 6 h

DRUG

Ondansetron 8mg

8 mg IV prn for nausea or vomiting q 8 h

Trial Locations (1)

Department of Anesthesiology, Faculty of Medicine, Chulalongkorn University, Pathum Wan

All Listed Sponsors

lead

Chulalongkorn University

OTHER